Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1776 to 1800 of 2545

TitleReference numberPublishedLast updated
Guidance on the use of imatinib for chronic myeloid leukaemiaTA70
Inflammatory lesions of papulopustular rosacea: ivermectin 10 mg/g creamESNM68
Preventing unintentional injury in under 15sQS107
Multiple sclerosisQS108
C3 glomerulopathy in the native kidney: eculizumabESUOM49
Older people: independence and mental wellbeingNG32
Bladder cancerQS106
Care of dying adults in the last days of lifeNG31
Abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritisTA373
Erlotinib and gefitinib for treating non-small-cell lung cancer that has progressed after prior chemotherapyTA374
Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tearsTA369
Bortezomib for previously untreated mantle cell lymphomaTA370
Electrical stimulation of the lower oesophageal sphincter for treating gastro-oesophageal reflux diseaseHTG395
Repetitive transcranial magnetic stimulation for depressionHTG396
Joint distraction for ankle osteoarthritisHTG393
Radiofrequency ablation for symptomatic interdigital (Morton's) neuromaHTG394
Insertion of a subretinal prosthesis system for retinitis pigmentosaHTG392
Restless legs syndrome: Oxycodone/naloxone prolonged releaseESNM67
AdenoPlus point-of-care test for diagnosing adenoviral conjunctivitisMIB46
TearLab osmolarity system for diagnosing dry eye diseaseMIB47
Oral health promotion: general dental practiceNG30
External genital and perianal warts: green tea (Camellia sinensis) leaf extract 10% ointmentESNM66
Acute heart failureQS103
Gallstone diseaseQS104
Type 2 diabetes mellitus in adults: high-strength insulin glargine 300 units/ml (Toujeo)ESNM65

Results per page

  1. 10
  2. 25
  3. 50
  4. All